MVA vaccine for delivery of a UL128 complex and preventing CMV infection Grant US-11717568-B2 United States of America 08 Aug 2023
MVA-gH/gL-PC vaccine derived antibodies neutralizing human cytomegalovirus infectivity… Grant US-11384137-B2 United States of America 12 Jul 2022
AMINO ACID SEQUENCE SEARCHING DEVICE, VACCINE, AMINO ACID SEQUENCE SEARCHING METHOD, AND… Application WO-2021106706-A1 World Intellectual Property Organisation (WIPO) 03 Jun 2021
MVA vaccine for delivery of a UL128 complex and preventing CMV infection Grant US-10842864-B2 United States of America 24 Nov 2020
MVA-gh/gL-PC vaccine derived antibodies neutralizing human cytomegalovirus infectivity… Grant US-10487139-B2 United States of America 26 Nov 2019
MVA vaccine for delivery of a UL128 complex and preventing CMV infection Grant US-10376575-B2 United States of America 13 Aug 2019
Antibody that specifically binds partially processed or unprocessed neurotoxin… Grant US-9963502-B2 United States of America 08 May 2018
ALPHA CHAIN OF THE HIGH-AFFINITY IGE RECEPTOR (FCERIA) Application WO-2017121842-A1 World Intellectual Property Organisation (WIPO) 20 Jul 2017
ALPHA CHAIN OF THE HIGH-AFFINITY IGE RECEPTOR (FCERIA) Application EP-3192806-A1 European Patent Office 19 Jul 2017
Means and methods for manufacturing highly pure neurotoxin Grant US-9447175-B2 United States of America 20 Sep 2016
DETECTION OF AN ANTIBODY AGAINST A PATHOGEN Application WO-2015095355-A2 World Intellectual Property Organisation (WIPO) 25 Jun 2015
MEANS AND METHODS FOR MANUFACTURING HIGHLY PURE NEUROTOXIN Application US-20120004179-A1 United States of America 05 Jan 2012